ANDHealth announces 2018 cohort

Latest News

Five digital health companies have been announced as the applicants for ANDHealth+ 2018, a market and investment readiness program for mid-stage digital health companies.

The five companies in the 2018 cohort were selected by an experienced industry selection panel from 42 submissions. They were announced by Victorian innovation minister Philip Dalidakis.

ANDHealth is a non-profit industry-led organisation established with the goal of strengthening the Australian digital health ecosystem.

It is comprised of a consortium of industry and government partners, with foundation members drawn from industry leaders nationally and internationally including Novartis Pharmaceuticals, RMIT University, Murdoch Children’s Research Institute, Planet Innovation, Curve Tomorrow, GP2U, AusBiotech, HealthXL, and HPM Executive. It has matching funding provided by MTPConnect.

The program is considered unique because it requires no equity consideration and each advisory panel and project is tailored specifically to that company.

Bronwyn Le Grice, managing director and CEO of ANDHealth, said: “We are excited to be working with these companies over the next six to nine months to bring their evidence-based technologies closer to market entry and investment readiness. If we can help Australian companies commercialise their digital health tech with a strong evidence base, then more Australians will be able to utilise them and effectively manage their health through digital technologies.”

The five successful companies in the ANDHealth+ 2018 cohort are:

  1. CancerAid
  2. Health Delivered
  3. Hello Sunday Morning
  4. Kesem Health
  5. Vitalic Medical

The companies will be supported by advisory panels drawn from ANDHealth members and networks.

ANDHealth will contribute $60,000 to securing relevant third-party expertise. Companies will also benefit from significant in-kind offerings including media and communications, insurance, access to a technical platform, human resources, intellectual property and legal support.

“I am thrilled with the return on investment that ANDHealth has generated and it is fantastic to know more evidence based digital health technologies will have a chance of making it in to the hands of everyday people," said ANDHealth chair Dr Anna Lavelle.